Loss of revenue due to medication non-adherence globally and U.S. 2012 vs. 2016
This statistic shows the loss of revenue due to medication non-adherence globally and in the U.S. in 2012 and in 2016. It shows that the pharmaceutical revenue loss globally was 564 billion U.S. dollars in 2012 and 637 billion U.S. dollars in 2016 due to non-adherence.